AIM Radio frequency (RF) catheter-based renal artery nerve ablation is under investigation for the treatment of patients with drug-resistant hypertension. Recent clinical results suggest that a four quadrant coverage is necessary to achieve optimal denervation. These results also suggest that increasing the number of ablation lesions improves denervation effectiveness. In the present study we evaluated the lesion characteristics and degree of arterial, circumferential coverage with RF ablation using the EnligHTNTM Multi-Electrode Renal Denervation System in the domestic swine animal model.
METHODS AND RESULTS
Theoretical modeling and preclinical ablation were conducted to develop an arterial lesion coverage algorithm. Twenty three domestic swine were randomly assigned to either treatment (ablation) groups or sham procedure groups. Animals in the treatment groups received simultaneous RF energy delivery from a four electrode basket catheter; whereas animals in the sham procedure groups were either naïve untreated animals or received only balloon dilation with no energy delivery. In the treatment arm two RF applications (8 lesions) were delivered per renal artery. The animals were terminated at three timepoints: acute, 30, and 90 days after the procedure. Acute necropsy findings showed four well-demarcated transmural lesions per RF application site on both luminal and adventitial surfaces of each renal artery. Observed lesion dimensions were 3.0 AE 0.4 width x 2.1 AE 0.3 length mm. The number of lesions needed for circumferential arterial coverage increased with the renal artery diameter as follows: Renal artery diameter (mm)Lesions needed for circumferential coverage 44.4, 55.5, 66.6, 77.7, 88.8 Kidneys were analyzed for norepinephrine (NE) levels at the time of sacrifice. Baseline NE levels were 367AE119.76 in the naïve animals and 342AE43 ng/g in the sham procedure group. The values decreased to 162AE15 (56% decrease)at 30 days, and 164AE43 ng/g (55% decrease) at 90 days in the 30, and 90 day RF treated groups, respectively. Immunohistochemistry and H&E stains indicated fiber interruption, fiber injury or inflammation and functional derailment in all affected fibers.
CONCLUSION Renal nerve ablation using the EnligHTNTM Multi-Electrode Denervation System provides uniform transmural lesions with longitudinal, circumferential arterial coverage. In order to obtain full circumferential coverage, the number of lesions needed increases with the renal artery diameter. AIMS Coronary computed tomography angiography (CTA) investigates not only coronary arteries but also coronary veins. The aim of this study was to clarify the anatomy of the crossing points and adjacent cardiac wall of coronary arteries and veins and to discuss the clinical relevance.
IMAGING
METHODS AND RESULTS Seventy-six coronary CTA images were retrospectively reviewed using the slab maximal intensity projection technique. Three vessel pairs were investigated: (i) the left circumflex artery (LCx)/coronary sinus (CS), (ii) the diagonal branch/anterior interventricular vein, and (iii) the atrioventricular node branch (#4AV)/posterior interventricular vein. Pattern A was defined when arteries ran between the vein and the muscle; pattern V was when the vein ran between the artery and the muscle. Pattern A was detected in 72%, 33%, and 93% of crossing points (i), (ii), and (iii), respectively. The A-V-A was the predominant pattern combination, accounting for 41% of the patients. The LCx/CS crossing point was adjacent to the anterior (58%), lateral (34%), or posterior (7%) wall, with distances between the LCx ostium and the crossing point of 24 AE 7.8, 39 AE 11, and 52 AE 20 mm, respectively.
CONCLUSION The crossing point anatomy of coronary arteries and veins showed typical patterns with some variation. These data could be used in clinical settings to (a) prevent arterial spasm or occlusion by radiofrequency ablation within the CS, (b) prevent LCx occlusion by the intra-CS implant of the Carillon Ò Mitral Contour SystemTM, and (c) predict the difficulty of wiring during percutaneous coronary intervention at the crossing point.
CRT-401
Ivabradine Versus Metoprolol For Heart Rate Reduction In Computed Tomography Coronary Angiography Chicago, IL BACKGROUND Ivabradine, a sinus node blocker, has been evaluated in multiple studies for heart rate reduction in computed tomography coronary angiography (CTCA). We aimed to performed a meta-analysis of studies comparing Ivabradine with Metoprolol for the same.
METHODS Pubmed, EBSCO and Cochrane databases were searched for terms "Ivabradine", "Metoprolol", "computed tomography coronary angiography" and their combinations. Only studies in English language and reporting data in usable format were included. Random effects model was used for heterogeneity. A 'p' value of <0.05 was considered significant. Review manager was used for statistical analysis.
RESULTS A total of 4 studies with total 357 patients were included. Ivabradine was found to significantly decrease heart rate when compared to metoprolol (Mean difference -8.02, 95% CI -11.12 to -4.92, p <0.00001).
CONCLUSION Ivabradine use was associated with significant reduction in heart rate when compared to metoprolol in use for computed tomography coronary angiography. 
